Sensus Healthcare, Inc. financial data

Symbol
SRTS on Nasdaq
Location
Boca Raton, FL
Fiscal year end
31 December
Latest financial report
04 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 821% % -21%
Quick Ratio 202% % -13%
Debt-to-equity 13% % 16%
Return On Equity -15% % -222%
Return On Assets -13% % -220%
Operating Margin -38% % -294%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16,462,059 shares 0.1%
Common Stock, Shares, Outstanding 16,463,809 shares -0.19%
Entity Public Float $70,888,700 USD -11%
Common Stock, Value, Issued $169,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 16,326,937 shares 0.09%
Weighted Average Number of Shares Outstanding, Diluted 16,326,937 shares -0.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $27,482,000 USD -34%
Revenue from Contract with Customer, Excluding Assessed Tax $27,482,000 USD -34%
Cost of Revenue $3,599,000 USD 89%
Research and Development Expense $7,778,000 USD 84%
Selling and Marketing Expense $6,523,000 USD 31%
General and Administrative Expense $5,683,000 USD 0.62%
Operating Income (Loss) $10,307,000 USD -227%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $9,624,000 USD -207%
Income Tax Expense (Benefit) $1,905,000 USD -180%
Net Income (Loss) Attributable to Parent $7,719,000 USD -216%
Earnings Per Share, Basic -0.47 USD/shares -215%
Earnings Per Share, Diluted -0.47 USD/shares -215%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $22,083,000 USD 0.12%
Accounts Receivable, after Allowance for Credit Loss, Current $6,041,000 USD -69%
Inventory, Net $14,563,000 USD 44%
Other Assets, Current $1,683,000 USD 12%
Assets, Current $45,892,000 USD -19%
Deferred Income Tax Assets, Net $4,079,000 USD 86%
Property, Plant and Equipment, Net $1,976,000 USD -1.1%
Operating Lease, Right-of-Use Asset $452,000 USD -22%
Other Assets, Noncurrent $640,000 USD -1.8%
Assets $53,039,000 USD -15%
Contract with Customer, Liability, Current $686,000 USD
Liabilities, Current $4,722,000 USD -20%
Contract with Customer, Liability, Noncurrent $66,000 USD
Operating Lease, Liability, Noncurrent $209,000 USD -47%
Liabilities $4,941,000 USD -22%
Retained Earnings (Accumulated Deficit) $5,715,000 USD -57%
Stockholders' Equity Attributable to Parent $48,098,000 USD -14%
Liabilities and Equity $53,039,000 USD -15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,677,000 USD 67%
Net Cash Provided by (Used in) Financing Activities $300,000 USD
Net Cash Provided by (Used in) Investing Activities $7,000 USD 97%
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 17,056,845 shares 0.12%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $22,083,000 USD 0.12%
Deferred Tax Assets, Valuation Allowance $446,000 USD 141%
Deferred Tax Assets, Gross $4,537,000 USD 89%
Operating Lease, Liability $471,000 USD -22%
Depreciation $386,000 USD 62%
Payments to Acquire Property, Plant, and Equipment $7,000 USD -97%
Lessee, Operating Lease, Liability, to be Paid $495,000 USD -23%
Property, Plant and Equipment, Gross $4,190,000 USD 7.7%
Operating Lease, Liability, Current $262,000 USD 28%
Lessee, Operating Lease, Liability, to be Paid, Year Two $214,000 USD -9.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $281,000 USD 23%
Operating Lease, Weighted Average Discount Rate, Percent 0.0532 pure 6.4%
Deferred Income Tax Expense (Benefit) $110,000 USD -87%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $24,000 USD -45%
Lessee, Operating Lease, Liability, to be Paid, Year Three $181,000 USD -23%
Deferred Tax Assets, Operating Loss Carryforwards $2,230,000 USD 245%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Additional Paid in Capital $46,090,000 USD 0.64%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $4,091,000 USD 84%
Share-based Payment Arrangement, Expense $5,000 USD 150%
Interest Expense $183,000 USD 12%